To report the development of panurethral stricture disease and other lower urinary tract abnormalities as a complication of photovaporization of the prostate (PVP).
Patients and Methods:
We evaluated three patients who were referred for the treatment of urethral stricture disease after PVP. Evaluation included antegrade cystoscopy, urethroscopy, retrograde urethrography, and cystourethrography.
Results:
All three patients had panurethral stricture disease, and a low capacity bladder with bilateral vesicoureteral reflux had developed in one patient as a complication of PVP.
Conclusions:
Although not previously reported, a potential complication of PVP is devastating panurethral stricture disease.
Get full access to this article
View all access options for this article.
References
1.
Bouchier-HayesD, Van AppledornS, BugejaPet al.A randomized trial of photoselective vaporization of the prostate using 80-W potassium-titanyl-phosphate laser vs transurethral prostatectomy, with a 1-year follow-up. BJU Int, 2010; 105:964–969.
2.
Van CleynenbreugelBV, SrirangamSJ, Van PoppelH. High-performance system GreenLight laser: Indications and outcomes. Curr Opin Urol, 2009; 19:33–37.
3.
WatsonG. Contact laser prostatectomy. World J Urol, 1995; 13:115–118.
4.
SountoulidesP, TsakirisP. The evolution of KTP laser vaporization of the prostate. Yonsei Med J, 2008; 49:189–199.
5.
GreenLight.™ American Medical Systems, Minnetonka, MN. www.greenlighthps.com. 2012 January 19.
6.
BachmannA, RuszatR. The KTP-(greenlight-) laser—principles and experiences. Minim Invasive Ther Allied Technol, 2007; 16;1:5–10.
7.
AhoTF, GillingPJ. Current techniques for laser prostatectomy—PVP and HoLEP. Arch Esp Urol, 2008; 61:1005–1013.
8.
TeAE. The next generation in laser treatments and the role of GreenLight High-Performance System laser. Rev Urol, 2006; 8,suppl 3:S24–S30.
9.
JensenV. The TURP syndrome. Can J Anesth, 1991; 38,1:90–97.
10.
CollinsJW, MacdermottS, BradbrookRA. The effect of the choice of irrigation fluid on cardiac stress during transurethral resection the prostate: A comparison between 1.5% glysine and 5% glucose. J Urol, 2007; 177:1369–1373.
11.
WooH, ReichO, BachmannAet al.Outcome of Greenlight HPS 120-W laser therapy in specific patient populations: Those in retention, on anticoagulants, and with large prostates. Eur Urol, 2008; 7,suppl 7:378–383.
12.
AhmedH, ThwainiA, ShergillISet al.Greenlight prostatectomy: A challenge to the gold standard? A review of KTP photoselective vaporization of the prostate. Surg Laparosc Endosc Percutan Tech, 2007; 17:156–163.
13.
Gomez SanchaF, BachmannA, ChoiBBet al.Photoselective vaporization of the prostate (GreenLight PV): Lessons learnt after 3500 procedures. Prostate Cancer Prostatic Dis, 2007; 10:316–322.
14.
Al-AnsariA, YounesN, SampigeVPet al.GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for treatment of benign prostatic hyperplasia: A randomized clinical trial with midterm follow-up. Eur Urol, 2010; 58:349–355.
15.
MamoulakisC, TrumpetterM, de la RosetteJ. Bipolar transurethral resection of the prostate: The ‘golden standard’ reclaims its leading position. Curr Opin Urol, 2009; 19:26–32.
16.
SallM, BruskewitzRC. Prostatic urethral strictures after transurethral microwave thermal therapy for benign prostatic hyperplasia. Urology, 1997; 50;6:983–985.
17.
LumenN, HoebekeP, WillemsenPet al.Etiology of urethral stricture disease in the 21st century. J Urol, 2009; 182:983–987.
